Orion Minerals Limited (ASX:ORN) Announces Leadership Transition
Orion Minerals (ASX:ORN) appoints Tony Lennox as new CEO, succeeding Errol Smart after key milestones achieved in South African projects.
Breville Group Limited (ASX:BRG) Announces Response to US Tariffs
Breville Group Limited (ASX:BRG) outlines strategies to mitigate the impact of new US tariffs, maintaining its FY25 EBIT growth guidance.
Green Technology Metals (ASX:GT1) Enhances Lithium Resources at Root Project
Green Technology Metals (ASX:GT1) reports a 38% increase in Root Project’s lithium resources, reinforcing its position in Ontario’s lithium market.
Echo IQ (ASX:EIQ) Partners with Mayo Clinic Platform, Advances EchoSolv HF towards FDA Clearance
Echo IQ (ASX:EIQ) partners with Mayo Clinic Platform to advance EchoSolv HF and progress towards FDA clearance for its heart failure solution.
US MASTERS RESIDENTIAL PROPERTY FUND (ASX:URF) Announces AUD0.01 Dividend
US MASTERS Residential Property Fund (ASX:URF) declares a AUD0.01 dividend, with payment scheduled for 1 May 2025.
Cann Group Limited (ASX:CAN) Executes Supply Agreements with Chemist Warehouse
Cann Group Limited (ASX:CAN) signs supply agreements with Queensland’s Chemist Warehouse outlets to distribute its medicinal cannabis products.
Race Oncology (ASX:RAC) Activates First Australian Clinical Site for RC220 Trial
Race Oncology (ASX:RAC) initiates its first Australian clinical site for the Phase 1 RC220 trial, marking a significant step in advancing cancer treatment.
Gold Mountain Limited (ASX:GMN) Announces Entitlement Offer and Director Appointment
Gold Mountain Limited (ASX:GMN) announces a $3.05m entitlement offer and appoints a new director to support its exploration initiatives.
Bioxyne Limited (ASX:BXN) Signs Exclusive $7M Agreement with NectarTek
Bioxyne Limited (ASX:BXN) secures a $7 million manufacturing agreement with NectarTek, significantly increasing FY2026 revenue projections.
Biome Australia Limited (ASX:BIO) Secures $5.0M Debt Facility with NAB
Biome Australia Limited (ASX:BIO) secures a $5.0 million debt facility with NAB to drive growth and enhance financial stability.